Litigation

Recent Posts

N.J. Appeals Court: Hormone Replacement Therapy Plaintiffs Didn't Rebut Label Adequacy
Posted on 3 Oct 2011 by Tom Moylan

TRENTON, N.J. - (Mealey's) A New Jersey appeals court panel on Sept. 29 affirmed summary judgment in two hormone replacement therapy (HRT) cases in which the state's mass tort court found that the plaintiffs failed to present sufficient evidence... Read More

Utah Federal Jury Awards HRT Breast Cancer Plaintiff $5.1 Million Compensatory Verdict
Posted on 10 Sep 2012 by Tom Moylan

SALT LAKE CITY - (Mealey's) A Utah federal jury on Sept. 7 awarded a hormone replacement therapy plaintiff $5.1 million in compensatory damages after finding that her breast cancer was caused by Premarin, Provera and Prempro and that manufacturer... Read More

Connecticut Federal Jury Finds Warning Adequate In Prempro Wrongful Death Suit
Posted on 31 May 2012 by Tom Moylan

BRIDGEPORT, Conn. - (Mealey's) Wyeth is not liable for the breast cancer death of a woman who took the company's hormone therapy drugs Premarin and Prempro, a Connecticut federal jury said May 30, finding that the drugs' labeling contained... Read More

U.S. Supreme Court Declines To Hear Prempro/Premarin Punitive Damages Appeal
Posted on 20 Jun 2011 by Tom Moylan

WASHINGTON, D.C. - (Mealey's) The U.S. Supreme Court on June 20 declined to review a Nevada Supreme Court decision affirming a $35 million punitive damages award in a Prempro/Premarin injury case ( Wyeth LLC, et al., v. Jeraldine Scofield, et al.... Read More

Pennsylvania Jury Awards $72.6 Million To 3 Women In HRT Breast Cancer Case
Posted on 7 Dec 2011 by Tom Moylan

PHILADELPHIA - (Mealey's) A Pennsylvania state court jury on Dec. 6 awarded $72.6 million to three women who say they developed breast cancer after taking hormone replacement therapy (HRT) drugs made by subsidiaries of Pfizer Inc. ( Susan Elfont,... Read More